136 related articles for article (PubMed ID: 33517655)
61. Low affinity of Trypanosoma brucei transferrin receptor to apotransferrin at pH 5 explains the fate of the ligand during endocytosis.
Maier A; Steverding D
FEBS Lett; 1996 Oct; 396(1):87-9. PubMed ID: 8906872
[TBL] [Abstract][Full Text] [Related]
62. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention.
Sahoo SK; Labhasetwar V
Mol Pharm; 2005; 2(5):373-83. PubMed ID: 16196490
[TBL] [Abstract][Full Text] [Related]
63. Transferrin-conjugated nanodiamond as an intracellular transporter of chemotherapeutic drug and targeting therapy for cancer cells.
Wang D; Li Y; Tian Z; Cao R; Yang B
Ther Deliv; 2014 May; 5(5):511-24. PubMed ID: 24998271
[TBL] [Abstract][Full Text] [Related]
64. Development of Core-Shell Nanostructures by In Situ Assembly of Pyridine-Grafted Diblock Copolymer and Transferrin for Drug Delivery Applications.
Lu L; Yuan L; Yan J; Tang C; Wang Q
Biomacromolecules; 2016 Jul; 17(7):2321-8. PubMed ID: 27251028
[TBL] [Abstract][Full Text] [Related]
65. Characterization and modulation of the transferrin receptor on brain capillary endothelial cells.
Visser CC; Voorwinden LH; Crommelin DJ; Danhof M; de Boer AG
Pharm Res; 2004 May; 21(5):761-9. PubMed ID: 15180331
[TBL] [Abstract][Full Text] [Related]
66. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
67. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
[TBL] [Abstract][Full Text] [Related]
68. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway.
Qian ZM; Li H; Sun H; Ho K
Pharmacol Rev; 2002 Dec; 54(4):561-87. PubMed ID: 12429868
[TBL] [Abstract][Full Text] [Related]
69. Internalization of transferrin-tagged
Gabashvili AN; Alexandrushkina NA; Mochalova EN; Goliusova DV; Sapozhnikova EN; Makarevich PI; Nikitin PI
Exp Biol Med (Maywood); 2024; 249():10055. PubMed ID: 38774281
[TBL] [Abstract][Full Text] [Related]
70. Polydopamine-based functional composite particles for tumor cell targeting and dual-mode cellular imaging.
Zhou Y; Zhou J; Wang F; Yang H
Talanta; 2018 May; 181():248-257. PubMed ID: 29426509
[TBL] [Abstract][Full Text] [Related]
71. [Chrono-drug delivery system based on the circadian rhythm of transferrin receptor].
Matsunaga N; Okazaki F; Koyanagi S; Ohdo S
Nihon Rinsho; 2013 Dec; 71(12):2200-5. PubMed ID: 24437279
[TBL] [Abstract][Full Text] [Related]
72. Noncanonical interactions between serum transferrin and transferrin receptor evaluated with electrospray ionization mass spectrometry.
Leverence R; Mason AB; Kaltashov IA
Proc Natl Acad Sci U S A; 2010 May; 107(18):8123-8. PubMed ID: 20404192
[TBL] [Abstract][Full Text] [Related]
73. Brefeldin A enhances receptor-mediated transcytosis of transferrin in filter-grown Madin-Darby canine kidney cells.
Wan J; Taub ME; Shah D; Shen WC
J Biol Chem; 1992 Jul; 267(19):13446-50. PubMed ID: 1618847
[TBL] [Abstract][Full Text] [Related]
74. The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells.
Bourseau-Guilmain E; Griveau A; Benoit JP; Garcion E
PLoS One; 2011; 6(9):e25515. PubMed ID: 21966538
[TBL] [Abstract][Full Text] [Related]
75. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
[TBL] [Abstract][Full Text] [Related]
76. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery.
Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y
Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663
[TBL] [Abstract][Full Text] [Related]
77. Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor.
Papademetriou J; Garnacho C; Serrano D; Bhowmick T; Schuchman EH; Muro S
J Inherit Metab Dis; 2013 May; 36(3):467-77. PubMed ID: 22968581
[TBL] [Abstract][Full Text] [Related]
78. Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting.
Chiu RY; Tsuji T; Wang SJ; Wang J; Liu CT; Kamei DT
J Control Release; 2014 Apr; 180():33-41. PubMed ID: 24524898
[TBL] [Abstract][Full Text] [Related]
79. Dendroaxonal transcytosis of transferrin in cultured hippocampal and sympathetic neurons.
Hémar A; Olivo JC; Williamson E; Saffrich R; Dotti CG
J Neurosci; 1997 Dec; 17(23):9026-34. PubMed ID: 9364049
[TBL] [Abstract][Full Text] [Related]
80. The dynamic morphology of the transferrin-transferrin receptor system in human leukaemia/lymphoma cell lines and its relation to iron metabolism and cell proliferation.
Forsbeck K; Nilsson K
Scand J Haematol; 1985 Aug; 35(2):145-54. PubMed ID: 2996121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
